Telemonitoring kids at risk of chemotherapy infection
Part of Blood & lymphatic clinical trials.
This trial tests a home monitoring device to help families of children with cancer who are at risk of infection from low white blood cells. The device may help catch problems early and reduce hospital visits.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 0 to 17 years old.
- You are being treated for a first-time solid or blood cancer.
- You have already received your first round of chemotherapy.
- Your family has some psychosocial challenges, like needing extra nursing support at home.
- You do not have a skin condition that prevents using the device.
- You agree to take part in the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies whether proteins in your blood can predict complications when you have a fever and very low white blood cells after cancer treatment. It aims to help doctors choose the best antibiotics early on.
This study tests a way to continuously monitor fever in children getting cancer treatment that suppresses the bone marrow. It may help doctors detect fever episodes earlier and respond faster during periods when infection risk is higher.
This trial tests a smartphone app and wearable sensor to track your temperature after leaving the hospital, alerting you or your doctors if a fever develops. It aims to catch fevers early so you can get faster care.
This trial tests whether using a smartphone app to report symptoms helps patients feel better and manage side effects during cancer treatment. If you have cancer at any stage and are on systemic therapy, you may be able to join.
This trial tests whether using a mobile app to track daily medication and weekly blood tests can help children with acute lymphoblastic leukemia (ALL) continue maintenance therapy safely at home, without needing to stay in the hospital.
This study tests whether cancer patients can do their own blood counts at home using a finger-prick test. It will help see if home monitoring is a good option for people receiving chemotherapy.
Hear when a new Febrile Neutropenia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.